Latest News

Dr. Wu Summary On Coronavirus Study

Posted by on Mar 19, 2020 in news | 0 comments

Brief Summary: The 2019 novel coronavirus pneumonia first emerged in Wuhan, Hubei, China, in December 2019. The disease spread quickly to 26 countries worldwide representing a serious global public health threat. Common signs of infection include respiratory symptoms, fever, dry cough, shortness of breath and breathing difficulties. In more severe cases, the infection can cause pneumonia, severe acute respiratory system injury with overwhelming inflammation in the lung. To date, there are no anti-viral therapeutics that specifically target...

read more

Brian Mehling, MD participates in 9th Annual Brain Mapping Day

Posted by on Feb 28, 2020 in news | 0 comments

Brian Mehling, MD participates in 9th Annual Brain Mapping Day

Brian Mehling, MD participated in the 9th Annual Brain Mapping Day: A joint Congressional briefing with the Society for Brain Mapping and Therapeutics, Brain Mapping Foundation, and the Congressional Neuroscience Caucus yesterday in Washington DC. The topic of Dr. Mehling’s presentation was “Safety and Efficacy of Stem Cell Therapy in Clinical Applications.” The materials presented focused on educating lawmakers about new technologies and innovations in the field of neuroscience, including stem cell therapy, enabling...

read more

BHI Therapeutic Sciences Jamaica celebrates one year anniversary

Posted by on Feb 18, 2020 in news | 0 comments

A little more than one year ago, BHI Therapeutic Sciences Jamaica (BHI Jamaica), located in Montego Bay opened its doors and welcomed its first stem cell therapy patients. Since then, more than 50 patients have been treated with advanced stem cell therapies.   Brian Mehling, MD said: “Cellular medicine is in high demand and stem cells have the potential to treat a wide range of diseases. Stem cells are essentially “blank slate” cells that possess the remarkable potential to differentiate to any one of the billions of cells...

read more

Brian Mehling, MD, (R) and Dongecheng Wu, MD, Ph.D., (L) during the stem cell applications at BHI Jamaica.

Posted by on Feb 17, 2020 in news | 0 comments

Brian Mehling, MD, (R) and Dongecheng Wu, MD, Ph.D., (L) during the stem cell applications at BHI Jamaica.

Dr. Mehling is the founder and chief medical officer of Mehling Orthopedics and BHI Therapeutic Sciences (BHITS). He is a practicing American orthopedic trauma surgeon, researcher, and philanthropist. He is also spearheading groundbreaking research in stem cell therapy. Notably, BHITS is currently engaged in an FDA Investigational New Drug trial for stroke, using human umbilical cord blood (hUCB) stem cells. Completing his degree of medicine at Wright State University School of Medicine, Dr. Mehling received post graduate education...

read more

Stem Cells Quality Reports

Posted by on Feb 17, 2020 in news | 0 comments

Stem Cells Quality Reports

BHI Therapeutic Sciences is pioneering ethical, effective, safe and affordable stem cell treatment therapies utilizing cord blood stem cells. Its stem cell products evaluated in clinical studies are collected in accordance with Good Tissue Practice to ensure safety.  The studies have been conducted following approval by an Investigational Research Board and in accordance with Good Clinical Practice. Results show its cellular products are safe and effective in the improvement of symptoms related to chronic inflammation, spinal...

read more

BRIAN MEHLING, MD RECEIVES 2020 BEST OF WEST ISLIP AWARD

Posted by on Feb 6, 2020 in news | 0 comments

Brian Mehling, MD, an orthopedic trauma surgeon, has been selected for the 2020 Best of West Islip Award in the Physicians & Surgeons category by the West Islip Award Program. Each year, the West Islip Award Program identifies companies and individuals that have achieved exceptional marketing success in their local community and business category. They enhance the positive image of small business through service to their customers and the community. As a result, the recipients help make the West Islip area a great place to live, work,...

read more

BHI THERAPEUTIC SCIENCES SCIENTIFIC ADVISORY BOARD CHAIRMAN RECEIVES APPROVAL TO USE STEM CELL PRODUCT IN CLINICAL TRIALS

Posted by on Feb 4, 2020 in news | 0 comments

A Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) product, developed by Wuhan Hamilton Biotechnology Co., Ltd., recently passed inspection by the China National Institute for Food and Drug Control. As a result, the UC-MSCs are a qualified product for application in clinical trials. Dongecheng Wu, MD, Ph.D., manager and chief scientist of Wuhan Hamilton Biotechnology Co., Ltd. and his team will begin a study entitled “Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis.” Dr. Wu is...

read more

Stem cells could be the medical innovation of the century

Posted by on Jan 30, 2020 in news | 0 comments

This article is part of the World Economic Forum Annual Meeting (Davos-Klosters, Switzerland 21—24 January 2020) The leading causes of death in 1900 were mostly infectious/communicable diseases. While the prevalence of most causes has diminished, the largest increases include heart disease (+40%) and cancer (+300%). Granted, this is partly due to doubling life expectancy and a lack of death from other causes. However, given time and resources, scientists and physicians may cure these challenging diseases. Today, six of...

read more

BRIAN MEHLING, MD TO PRESENT SPINAL CORD STEM CELL RESEARCH AT ANNUAL MEETING OF THE SOCIETY FOR BRAIN MAPPING AND THERAPEUTICS

Posted by on Jan 21, 2020 in news | 0 comments

Brian Mehling, MD has been invited to present his research at the 17th Annual World Congress of the Society for Brain Mapping and Therapeutics being held at the JW Marriott, in Los Angeles, California from Friday March 20-Sunday March 22. The conference will bring together physicians, scientists, policy makers, funding agencies and industry to further the advances and applications in brain and spinal cord mapping and image guided therapies (operative and non-operative). Dr. Mehling is the founder and chief medical officer of BHI...

read more